1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Central Nervous Systems Therapeutic Drug Monitoring Overview 6

3 Products under Development 7
3.1 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 7
3.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory 8
3.3 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path 9
3.4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date 10

4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products under Development by Companies 11
4.1 Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development 11
4.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 12

5 Central Nervous Systems Therapeutic Drug Monitoring Companies and Product Overview 13
5.1 Abbott Diagnostics Company Overview 13
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 ARK Diagnostics Inc Company Overview 14
5.2.1 ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Avacta Group Plc Company Overview 18
5.3.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 ELITechGroup Inc Company Overview 22
5.4.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Nipro Europe N.V. Company Overview 25
5.5.1 Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Pax Neuroscience Inc Company Overview 26
5.6.1 Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Saladax Biomedical Inc Company Overview 27
5.7.1 Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Siemens Healthineers AG Company Overview 28
5.8.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 University of Colorado Company Overview 32
5.9.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 32

6 Central Nervous Systems Therapeutic Drug Monitoring- Recent Developments 33
6.1 Aug 29, 2019: Siemens Healthineers announces new Cadian leadership 33
6.2 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 33
6.3 Jul 29, 2019: Changes in the Maging Board of Siemens Healthineers 34
6.4 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 35
6.5 Apr 09, 2019: Avacta Group: Interim results for the period ended 31 January 2019 36
6.6 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 38
6.7 Jan 28, 2019: Avacta Group mes Dr. Sam Williams as Non-Executive Director to the Board 39
6.8 Jan 21, 2019: Avacta Group announced its AGM business update and notice of results 39
6.9 Dec 12, 2018: Avacta Group mes Dr. Jose Saro as Chief Medical Officer 41
6.10 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 41
6.11 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 43
6.12 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 43
6.13 Oct 23, 2018: Leading Homegrown Medical Group, MWH Medical partners Siemens Healthineers to launch region’s first Asia Reference Centre 44

7 Appendix 46
7.1 Methodology 46
7.2 About GlobalData 49
7.3 Contact Us 49
7.4 Disclaimer 49